A Phase 1 Dose-escalation Study of FF-10832 for Treatment of Solid Tumors Including Biliary Tract Cancer
Clinical trial NCT03440450 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03440450
- Sponsor
- Fujifilm Pharmaceuticals U.S.A., Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-22
- Primary completion
- 2025-05-15
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.